https:\/\/insight.lunit.io\/<\/a>. The platform delivers Lunit\u2019s state-of-the-art AI models; the first one to be unveiled is the chest x-ray solution. Lunit\u2019s chest x-ray solution detects major chest abnormalities, lung nodule\/mass, consolidation, and pneumothorax, with an unprecedented high level of accuracy \u4e00 97% standalone accuracy in nodule detection, 99% for consolidation and pneumothorax.<\/p>\n<\/p>\n
According to the National Lung Screening Trial (NLST), one of the largest clinical trials conducted on lung cancer screening, 26.5% of lung cancer cases were shown to be missed by chest x-ray. Worldwide, more than 1 billion chest x-ray exams are performed every year. Decreasing the proportion of missed cases even by 10% would translate into significant clinical benefit.<\/p>\n
<\/p>\n
What\u2019s foremost remarkable is how Lunit\u2019s AI solutions have been proven to significantly increase the diagnostic performance of its users up to 20%, from non-radiology physicians to radiology experts. Lunit\u2019s solutions are designed to augment the diagnostic performance level of its users as the \u201csecond reader,\u201d not replace them.<\/p>\n
\u201cLunit\u2019s vision is to develop advanced software for medical data analysis and interpretation that goes beyond the level of human vision,\u201d said Anthony S. Paek, CEO of Lunit. \u201cIn presenting Lunit INSIGHT, we hope to contribute in opening a new era of medical practice, by helping and empowering healthcare professionals to make more accurate, consistent, and efficient clinical decisions for the patients.\u201d<\/p>\n
<\/p>\n
Users can upload their medical images via online, at Lunit INSIGHT webpage. AI analysis results appear in just a few seconds, including not only the level of abnormality, but also the visualization of the AI\u2019s attention map. Lunit\u2019s solutions will also be presented integrated into the systems of various companies including Nuance, EnvoyAI, and Infinitt Healthcare.<\/p>\n
<\/p>\n
\u201cFeatured\u201d in RSNA; development in process for mammography solution<\/strong><\/p>\n<\/p>\n
<\/p>\n
Lunit was chosen as \u201cfeatured\u201d exhibitor of RSNA in a consecutive two year since its initial presentation last year. This year, Lunit\u2019s exhibition booth is part of the \u201cmachine learning showcase,\u201d along with Google Cloud, NVIDIA, and other top exhibitors. On Tuesday, 28 November, Brandon B. Suh, Chief Medical Officer, will give a presentation, \u201cLunit INSIGHT: Toward Beyond-Human-Level AI for Medical Imaging Modalities,\u201d at Machine Learning Theater. A press conference and demonstration at Lunit booth will be followed shortly after the presentation.<\/p>\n
<\/p>\n
In order to launch meaningful AI solutions that has high clinical impact, proper clinical validation is an important part of the process. \u201cLarge-scale multi-center reader studies are set to be conducted in early 2018,\u201d said Suh, Chief Medical Officer of Lunit. \u201cThese are the studies with multiple leading hospitals in Korea and the US for Lunit\u2019s chest x-ray and mammography solutions; publication of the results are targeted for late 2018.\u201d FDA approval for Lunit\u2019s chest x-ray and mammography solutions are expected to be achieved by end of 2018.<\/p>\n
<\/p>\n
Other than the chest x-ray solution, Lunit\u2019s mammography solution to detect suspicious breast cancer lesions is in its final stages of development. Lunit INSIGHT for Mammography is expected to be publically released by the first quarter of 2018. Lunit is also doing research in developing solutions for digital breast tomosynthesis, chest CT, and coronary CT angiography.<\/p>\n
<\/p>\n
<\/p>\n
<\/p>\n
About Lunit<\/strong><\/p>\n<\/p>\n
<\/p>\n
Founded in 2013, Lunit develops advanced medical image analytics and novel imaging biomarkers via cutting-edge deep learning technology, in order to empower healthcare practitioners to make more accurate, consistent, and efficient clinical decisions. Lunit was chosen as Top AI startups in healthcare industry by CB Insights in 2017 and also was listed as \u201cTop 5 AI startups for social impact\u201d by Nvidia. Lunit is based in Seoul, South Korea.<\/p>\n
<\/p>\n
<\/p>\n